While it seems natural to assume that elevated CSF p-tau181 is associated with tau pathology in the brain, recent evidence suggests that elevated CSF p-tau181 is more likely associated with increased phosphorylation or secretion of tau from neurons associated with amyloid pathology [16–19]. Here, MAPT is linked to amyloidosis.